Insights from 2023 Society of Urologic Oncology Annual Meeting
SUO 2023 Insights: "BOND-003 Study of Cretostimogene Grenadenorepvec Monotherapy for Patients With BCG-Unresponsive NMIBC With CIS +/- Papillary (TaT1) Tumors"
Comments 0
Login to view comments.
Click here to Login
